share_log

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 15 16:51
Summary by Moomoo AI
CRISPR Therapeutics AG officer and director Samarth Kulkarni is set to sell 20,000 shares of common stock on 03/15/2024, with an aggregate market value of $1,449,628. The shares to be sold were acquired on the same date through a stock option exercise from the issuer, with payment made in cash. This transaction follows a series of sales over the past three months, where a total of 110,755 shares were sold for gross proceeds of $7,498,550.49.
CRISPR Therapeutics AG officer and director Samarth Kulkarni is set to sell 20,000 shares of common stock on 03/15/2024, with an aggregate market value of $1,449,628. The shares to be sold were acquired on the same date through a stock option exercise from the issuer, with payment made in cash. This transaction follows a series of sales over the past three months, where a total of 110,755 shares were sold for gross proceeds of $7,498,550.49.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more